Profile
| Metric | Value |
|---|---|
| Full Name | Erasca, Inc. |
| Ticker | NASDAQ: ERAS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | erasca.com |
| Employees | 103 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.44 | |
| Price, 1D Change | -1.31% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.12 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$0.69 | |
| EPS, 1Y Change | +16.96% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.69 | |
| EPS Estimate | -$0.29 | |
| EPS Est. Change | +57.38% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $9.44 | |
| Price Target | - | $5.00 |
| Price Tgt. Change | - | -47.01% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.91 | -$0.83 | +8.51% | |
| -$0.75 | -$0.69 | +7.34% | |
| -$0.29 | N/A | +57.38% | |
| -$0.48 | N/A | +31.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +407.26% | |
| Price, 3Y | +126.80% | |
| Market Cap, 1Y | +408.14% | |
| Market Cap, 3Y | +330.89% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +16.96% | |
| EPS, 3Y | +32.92% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.44 | |
| SMA 200 | $2.12 | |
| SMA 200 vs Price | -77.49% | |
| SMA 50 | $3.66 | |
| SMA 50 vs Price | -61.26% | |
| Beta | 1.12 | |
| ATR | $0.76 | |
| 14-Day RSI | 87.68 | |
| 10-Day Volatility | 232.28% | |
| 1-Year Volatility | 100.15% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$0.69 | |
| Gross Profit | -$3.81M | |
| - | ||
| Operating Profit | -$157.09M | |
| Operating Margin | - | |
| Net Income | -$161.65M | |
| Net Margin | - | |
| EBITDA | -$153.28M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.12 | |
| 9.84 | ||
| 9.84 | ||
| - | ||
| - | ||
| 17.82 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 7.69 | ||
| -18.56 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $423.50M | |
| $67.74M | ||
| $502.53M | ||
| $308.79M | ||
| $79.03M | ||
| $31.40M | ||
| Total Debt | $51.89M | |
| $4.62M | ||
| $468.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $157.09M | ||
| $157.09M | ||
| $3.81M | ||
| $41.73M | ||
| $3.81M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$109.42M | ||
| -$156.62M | ||
| $240.70M | ||
| Capex | $60.00K | |
| -$131.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | ||
| Mizuho | → | |
| Guggenheim | → | |
| Stifel | ||
| B of A Securities | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| Raymond James | ||
| HC Wainwright & Co. | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with ERAS
Data Sources & References
- ERAS Official Website www.erasca.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1761918/000119312525277625/0001193125-25-277625-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1761918/000095017025042682/0000950170-25-042682-index.htm
- ERAS Profile on Yahoo Finance finance.yahoo.com/quote/ERAS
- ERAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/eras
FAQ
What is the ticker symbol for Erasca, Inc.?
The ticker symbol for Erasca, Inc. is NASDAQ:ERAS
Does Erasca, Inc. pay dividends?
No, Erasca, Inc. does not pay dividends
What sector is Erasca, Inc. in?
Erasca, Inc. is in the Healthcare sector
What industry is Erasca, Inc. in?
Erasca, Inc. is in the Biotechnology industry
What country is Erasca, Inc. based in?
Erasca, Inc. is headquartered in United States
When did Erasca, Inc. go public?
Erasca, Inc. initial public offering (IPO) was on July 16, 2021
Is Erasca, Inc. in the S&P 500?
No, Erasca, Inc. is not included in the S&P 500 index
Is Erasca, Inc. in the NASDAQ 100?
No, Erasca, Inc. is not included in the NASDAQ 100 index
Is Erasca, Inc. in the Dow Jones?
No, Erasca, Inc. is not included in the Dow Jones index
When was Erasca, Inc. last earnings report?
Erasca, Inc.'s most recent earnings report was on November 12, 2025
When does Erasca, Inc. report earnings?
The next expected earnings date for Erasca, Inc. is March 19, 2026